Further experiments are therefore necessary to determine if senescence is indeed a general adaptive pathway to chemotherapy, if this concerns only a specific subset of cancer cells and how this relies on the integrity of p53, p21, and p16 signaling or on specific oncogenic pathways. This evidence concerns the gene TP53 and cancer.